The Best Practices Guide was developed and published jointly by the Council for Responsible Nutrition and the Enzyme Technical Association to help promote the safe production and use of enzyme-containing dietary supplements and to facilitate transparency and uniformity in the dietary supplement and enzyme industries. The Best Practices Guide was prepared with input from the dietary supplement and enzyme industries and takes into account the current U.S. laws and government regulatory requirements. It reflects the most up-to-date science and industry thinking with regard to the safe handling of enzyme-containing dietary supplements and will be updated as best practices evolve. The Best Practices Guide is not intended to be a substitute for consultation with legal and [...]
The use of asparaginase to reduce acrylamide in certain food processing applications is included in both the U.S. Food and Drug Administration's Draft Guidance for Industry: Acrylamide in Foods, as well as FoodDrinkEurope's Acrylamide Toolbox.
A voluntary recall of enzyme preparations contaminated with the antibiotic chloramphenicol was recently announced by a U.S.-based enzyme company that imported and distributed the affected product. The chloramphenicol-contaminated enzyme products were imported from a small enzyme producer located in India. It has been reported that contaminated enzyme products from this Indian producer have also been imported into Europe, Japan and Canada. The safety and quality of our products is of paramount importance to the enzyme industry. The industry is working with the U.S. Food and Drug Administration (“FDA”), the Canadian Food Inspection Agency (“CFIA”), the European Food Safety Authority (“EFSA”), and the Food Safety Commission of Japan (“FSCJ”). The contaminated enzymes were [...]
Designed metalloenzymes made by modifying a native protein scaffold have shown unusually high levels of efficiency and longevity and have revealed new details about the way oxidases, the natural enzymes they mimic, may work. The study is an important step in efforts to design customized enzymes for a variety of potential biological and alternative-energy applications. Full article here.
FDA has extended the agency's memorandum of understanding (MOU) with the Association of American Feed Control Officials (AAFCO) through September 1, 2013. FDA will likely stop accepting requests to review new feed ingredient definitions in February, 2012. The full letter from FDA may be downloaded here: FDA response letter AAFCO MOU 4-5-12
The Natural Health Products Directorate (NHPD) will be seeking your feedback on proposed revisions to the enzyme abbreviated labelling standards (AbLS). In September 2011, NHPD published 12 AbLS for enzyme ingredients outlining the minimum documentation requirements and specifications for products containing these enzymes. Since posting the new AbLS, NHPD has been consulting with stakeholders regarding the requirements for products containing enzymes. As a result of these consultations, NHPD has revised the 12 AbLS for enzymes and developed a new Multi-Ingredient Enzyme AbLS. These will be published for a 30-day consultation period. Consultation starts from the time the documents are officially posted on the Health Canada website. Proposed Revised and New Enzyme Abbreviated [...]